Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2225 SEK | +10.15% | +4.46% | -97.78% |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 | |
05-16 | Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.78% | 28.85M | |
+34.65% | 50.93B | |
-0.33% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.73% | 26.02B | |
-22.37% | 18.9B | |
+7.95% | 13.21B | |
+24.32% | 12.17B | |
+28.95% | 12.16B |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Transcript : Xbrane Biopharma AB, Q4 2021 Earnings Call, Feb 24, 2022